Overview
Join us for an exclusive webinar that delves into the most groundbreaking studies and updates presented at the 2025 American Society of Clinical Oncology (ASCO) meeting. This webinar will focus on pivotal advancements in the treatment and management of lung cancer, providing valuable insights for healthcare professionals involved in lung cancer care.
- Evaluate the impact of neoadjuvant immunotherapy combined with chemotherapy on survival outcomes in patients with resectable NSCLC
- Examine the role of targeted therapy in the neoadjuvant setting for EGFR-mutated resectable NSCLC.
- Analyze novel therapeutic options beyond chemotherapy for relapsed small cell lung cancer.
- Assess emerging treatment strategies for EGFR-mutated NSCLC with acquired resistance to third-generation EGFR TKIs.
The IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
IASLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Evaluate the impact of neoadjuvant immunotherapy combined with chemotherapy on survival outcomes in patients with resectable NSCLC
- Examine the role of targeted therapy in the neoadjuvant setting for EGFR-mutated resectable NSCLC.
- Analyze novel therapeutic options beyond chemotherapy for relapsed small cell lung cancer.
- Assess emerging treatment strategies for EGFR-mutated NSCLC with acquired resistance to third-generation EGFR TKIs.
The IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
IASLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Share
Participants
Kaushal Parikh
MD
Assistant Professor of Oncology
Mayo Clinic
Luis Raez
MD, FACP, FCCP
Medical Director, Chief Scientific Officer
Memorial Cancer Institute (MCI)
Oncology Research Director of Memorial Health Care System (MHS)
Jamie Chaft
MD
Director of Early Stage Lung Cancer Research
Memorial Sloan Kettering Cancer Center
Patrick Forde
MD, M.B.B.Ch.
Director of Thoracic Oncology - Clinical Research Program and Associate Professor
John Hopkins University
Giannis Mountzios
MD
Director of the Oncology Department and Clinical Trials Unit
Henry Dunant Hospital Center
Julia K. Rotow
MD
Assistant Professor of Medicine
Dana-Farber Cancer Institute
